Exchange: NYSE·Updated 04:10 PM EDT
News
all
press releases
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty led a broader recovery.
Zacks
More News
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.
Zacks
Dole's Q2 Earnings Miss Estimates on Higher Fresh Fruit Costs
DOLE's Q2 earnings miss estimates as higher fruit sourcing, fuel and shipping costs pressured Fresh Fruit, despite strong Americas growth.
Zacks
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.
Zacks
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?
Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.
Zacks
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?
Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.
Zacks
Primo Brands Beats Q2 Earnings Estimates, Raises 2026 Sales Outlook
PRMB beats second-quarter earnings and sales estimates, fueled by spring and premium water, and raises its 2026 sales growth outlook.
Zacks
Bullish Two Hundred Day Moving Average Cross - MED
In trading on Tuesday, shares of Medifast Inc (Symbol: MED) crossed above their 200 day moving average of $11.20, changing hands as high as $13.44 per share. Medifast Inc shares are currently trading up about 37.2% on the day. The chart below shows the one year performance of...
Nasdaq News: Markets
Archer Daniels Q2 Earnings Beat on Crushing and Ethanol Strength
ADM adjusted earnings nearly double in the second quarter as oilseeds, ethanol and Nutrition gains fuel a raised 2026 outlook.
Zacks
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves
MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pressure from a shrinking coach network.
Zacks

Advertisement|Remove ads.